Código QR (código de barras bidimensional)

Real-world outcomes after switching from standard therapy to efgartigimod in five patients with chronic inflammatory demyelinating polyradiculoneuropathy: a case series study in Japan

BackgroundEfgartigimod, a neonatal Fc receptor blocker, has received regulatory approval for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in Japan in December 2024.AimsTo investigate the effectiveness and safety of efgartigimod in real-world clinical setting imme...

Fuld beskrivelse

Na minha lista:
Principais autores: Tatsuya Imai, Kenichi Irie, Shinichiro Mori, Tomoaki Hoshino, Toshihiro Ide, Takahisa Tateishi
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2026-03-01
Serier:Frontiers in Neurology
Fag:
case series study
chronic inflammatory demyelinating polyradiculoneuropathy
CIDP variant
efgartigimod
Japan
neonatal Fc receptor blocker
Online adgang:https://www.frontiersin.org/articles/10.3389/fneur.2026.1748826/full
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker